Eighty-six percent of people buying HealthCare.gov plans had at least three insurance companies to choose from this year.» Read More
Wednesday's tax deadline features some new Obamacare-related chores that need to be completed.
Australia is making it harder for parents to file personal objections against vaccination.
After millions of people get hit with the Obamacare tax penalty, the real pain will hit. And it's a gift to Republicans, says Jake Novak.
IBM is teaming with Apple, J&J and Medtronic in hopes of revolutionizing the health care industry.
Johnson & Johnson reports quarterly earnings that beat expectations despite a 7.2 percent drag on the strong dollar.
The rate of people without health coverage has reached a record low, dropping to 11.9 percent since the launch of Obamacare.
Several high-ranking bankers have left their jobs at major investment banks in the last 13 months amid a surge in U.S. health care deal activity.
Meet MEDi, the friendly robot designed to make painful procedures such as blood tests or vaccines stress-free for children.
About half the people who received federal money to help pay for their Obamacare insurance will repay some of that money this tax season.
It can cost $75,000 to $250,000, and the names keep getting stranger as companies balance regulator concerns with the desire to market the product.
The "Halftime Report" traders give their trades for the second half.
CNBC Pro teamed up with RBC Capital Markets to unveil some of the top ideas for the rest of 2015.
A new report reveals that official estimates for the nation's future health spending are nearly 11 percent less that previously projected.
Dr. Joseph Kim, Inovio Pharmaceuticals president and CEO, discusses how the company's $45 million Ebola grant will impact the development of drugs for both the prevention and treatment of the disease.
Goldman Sachs retracted a downgrade of health website operator WebMD issued before Wednesday's open, citing a calculation error.
Perrigo shares shot higher after news that Mylan proposed to buy Perrigo for $205 per share.
An estimated 6 million people will be subject to the penalty for not having health coverage in 2014. The fine is due this tax season.
Eric Schmidt, senior research analyst at Cowen & Co, explains why despite the outperformance in the biotech sector, there's more room to run.
Former NFL star Jack Brewer highlights a couple of companies investing in brain-related diseases such as Alzheimer's and Parkinson's.
Sermo - a "Facebook for doctors" - helps physicians connect with specialists. For one doctor, the service helped his cancer patient survive.
Get the best of CNBC in your inbox